Table 3.

Comparisons of the clinicopathologic characteristics between locoregional recurrence and systemic recurrence

Characteristic	Locoregional recurrence		Systemic recurrence		P-value
	n=27	%	n=61	%
Sex					0.275
Male	13	48.1%	37	60.7%
Female	14	51.9%	24	39.3%
Age					0.641
≤48	5	18.5%	14	23.0%
>48	22	81.5%	47	77.0%
Jaundice					0.675
No	4	14.8%	13	21.3%
Yes	23	85.2%	48	78.7%
Intraoperative transfusion					0.360
No	10	37.0%	29	47.5%
Yes	17	63.0%	32	52.5%
Operation time					0.350
≤6 hours	22	81.5%	44	72.1%
>6 hours	5	18.5%	17	27.9%
Tumor size					0.232
≤2.2 cm	10	37.0%	31	50.8%
>2.2 cm	17	63.0%	30	49.2%
Differentiation					0.108
Poor	8	29.6%	25	41.0%
Moderate	11	40.7%	29	47.5%
Well	8	29.6%	7	11.5%
Regional nodes examined					0.653
≤11	16	59.3%	33	54.1%
>12	11	40.7%	28	45.9%
T stage					0.174
T1	2	7.4%	5	8.2%
T2	13	48.1%	17	27.9%
T3	12	44.4%	39	63.9%
N stage					0.381
N0	20	74.1%	36	59.0%
N1	6	22.2%	20	32.8%
N2	1	3.7%	5	8.2%
TNM stage					0.157
l	12	44.4%	15	24.6%
ll	8	29.6%	21	34.4%
lll	7	25.9%	25	41.0%
Lymphovascular invasion					0.083
No	24	88.9%	42	68.9%
Yes	3	11.1%	19	31.1%
Postoperative complications					0.698
No	17	63.0%	41	67.2%
Yes	10	37.0%	20	32.8%
Adjuvant treatment					0.960
No	18	66.7%	41	67.2%
Yes	9	33.3%	20	32.8%